USE OF A DISTALLY-BASED FASCIO-CUTANEOUS SURAL FLAP FOR TISSUE DEFECTS OF THE LEG AND ANKLE

Abstract

Purpose of the study: We present our experience with the distal-based sural flap for lower leg tissue defects.

Material and methods: This consecutive retrospective series included 45 flaps in 45 patients, 36 men and 9 women, mean age 50 years. The size and the cause of the tissue loss were described as were the patients’ history and risk factors. The distally-based fasciocutaneous sural flap was used in all cases. The postoperative period as well as the quality of the final cover were analyzed.

Results: At mean follow-up of 45 months, 43 of the 45 faciocutaneous flaps survived. Cover of initial tissue defect was complete in 41 cases and partial in two. Two flaps failed, leading to limb amputation. For the 25 patients with no risk factor, all flaps resulted in perfect tissue cover. In the 20 patients with risk factors, perfect cover was achieved for 16; only 10 of 20 flaps had an uneventful history with simple healing process; partial necrosis developed in eight flaps and two flaps failed.

Discussion: The Distally-based fasciocutaneous sural flap is a very reliable method offering many possibilities for covering lower limb tissue loss from the upper third of the leg to the ankle and hindfoot. The limitations are patient-related. There are thus many indications. For bone infections, one stage tissue cover can be achieved by integrating the flap as part of the overall treatment for the bone-related injury. This flap has an excellent vascular supply which increases the local concentration of systemic antibiotics. The distally-based sural flap can also be used successfully in traumatology.

Conclusion: The distally-based sural flap is reliable and relatively easy to perform. It provides excellent cover for most tissue losses situated on the lower half of the leg and ankle. The limitations are patient-related.